Showing results (801-810 of 1,615) with videos related to
Sort By:
Pageof 162
Cancer Journal (Sudbury, Mass.)|September 29, 2026
Minimal Residual Disease (MRD) in Multiple Myeloma: From Prognostic Marker to Therapeutic CompassLuis-Esteban Tamariz-Amador, Paula Rodriguez-Otero, Andrea Manubens, et al.Cancer Journal (Sudbury, Mass.)|September 29, 2026
Tailoring Therapy for Frail and Elderly Myeloma PatientsThomas George, Raphael E SzalatCancer Journal (Sudbury, Mass.)|September 29, 2026
Monoclonal Antibodies and Antibody-Drug Conjugates: Expanding the Therapeutic Arsenal in Multiple MyelomaIoannis Ntanasis-Stathopoulos, Evangelos Terpos, Meletios-Athanasios DimopoulosCancer Journal (Sudbury, Mass.)|September 29, 2026
Risk Stratification in Myeloma: Defining Precision in the Genomic EraAnaïs Schavgoulidze, Jill CorreCancer Journal (Sudbury, Mass.)|September 29, 2026
Smoldering and Early Disease InterceptionBorja Puertas, Elena Alejo, María-Victoria MateosCancer Journal (Sudbury, Mass.)|September 29, 2026
T-Cell Redirecting Antibodies for the Treatment of Multiple Myeloma: Off-the-Shelf T-Cell ImmunityNiels W C J van de Donk, Febe Smits, Chloe O'Neill, et al.Cancer Journal (Sudbury, Mass.)|September 29, 2026
Beyond Immunomodulatory Drugs: Next-Generation Cereblon Modulators in Multiple MyelomaLorenzo Cani, Roberto Mina, Sagar LonialCancer Journal (Sudbury, Mass.)|June 3, 2025
Personalizing Approaches to Management of HPV+ Oropharyngeal CancerFan Zhu, Musaddiq AwanCancer Journal (Sudbury, Mass.)|September 20, 2001
Molecular pathology of pancreatic cancerR H Hruban, C Iacobuzio-Donahue, R E Wilentz, et al.Pageof 162